慢性湿疹的临床特征与综合诊疗进展
Clinical Features and Advances in Comprehensive Diagnosis and Treatment of Chronic Eczema
DOI: 10.12677/acm.2026.1662479, PDF,   
作者: 张 淞*:黑龙江中医药大学研究生院,黑龙江 哈尔滨;张 敏#:黑龙江中医药大学附属第三医院纪委办公室,黑龙江 哈尔滨;修 畅:黑龙江中医药大学附属第一医院内分泌二科,黑龙江 哈尔滨;白 静:黑龙江中医药大学附属第三医院胃肠镜外科,黑龙江 哈尔滨
关键词: 慢性湿疹病因机制临床表现诊疗进展皮肤屏障Chronic Eczema Pathogenesis Clinical Manifestations Diagnostic and Therapeutic Advances Skin Barrier
摘要: 慢性湿疹是一种累及真皮浅层及表皮的慢性炎症性皮肤病,以皮肤肥厚、粗糙、苔藓样变及剧烈瘙痒为核心特征,病程迁延反复,可发生于任何年龄和性别,严重影响患者生活质量。其病因复杂,尚未完全明确,与内外部因素共同作用密切相关,诊断需结合临床表现并与相似皮肤病鉴别,治疗以缓解症状、控制复发、修护皮肤屏障为核心,采用多维度综合干预方案。本文结合近年来国内外相关研究及临床诊疗指南,对慢性湿疹的病因机制、临床表现、诊断鉴别、治疗及护理进展进行综述,为临床诊疗及患者管理提供参考。
Abstract: Chronic eczema is a chronic inflammatory skin disease involving the superficial dermis and epidermis. It is mainly characterized by skin hypertrophy, roughness, lichenification and severe pruritus. With a protracted and recurrent course, it can occur in people of all ages and genders, seriously impairing patients’ quality of life. Its etiology is complex and not yet fully clarified, which is closely related to the combined effects of internal and external factors. Diagnosis needs to combine clinical manifestations and differentiate it from similar skin diseases. The core of treatment is to relieve symptoms, control recurrence and repair the skin barrier, adopting a multi-dimensional comprehensive intervention strategy. Based on relevant domestic and foreign studies as well as clinical diagnosis and treatment guidelines in recent years, this paper reviews the research progress on etiological mechanism, clinical manifestations, differential diagnosis, treatment and nursing of chronic eczema, so as to provide references for clinical diagnosis, treatment and patient management.
文章引用:张淞, 张敏, 修畅, 白静. 慢性湿疹的临床特征与综合诊疗进展[J]. 临床医学进展, 2026, 16(6): 2565-2573. https://doi.org/10.12677/acm.2026.1662479

参考文献

[1] 中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南(2020版) [J]. 中华皮肤科杂志, 2020, 53(2): 81-88.
[2] European Dermatology Forum (2025) European S1 Guideline for the Management of Chronic Eczema (2025). Journal of the European Academy of Dermatology and Venereology, 39, 12-35.
[3] 中华医学会皮肤性病学分会. 中国慢性湿疹临床流行病学调研数据(2025) [R]. 北京: 中华医学会, 2025.
[4] 赵辨. 中国临床皮肤病学[M]. 第二版. 南京: 江苏科学技术出版社, 2010: 708-712.
[5] 中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会. 中国皮炎湿疹类疾病诊疗指南(2026版) [J]. 中华皮肤科杂志, 2026, 59(4): 289-302.
[6] 陈红风. 中医皮肤性病学[M]. 北京: 中国中医药出版社, 2017: 123-127.
[7] Smith, J. and Jones, A. (2024) Long-Term Safety and Efficacy of Dupilumab in Patients with Moderate-to-Severe Chronic Eczema. JAMA Dermatology, 160, 1123-1130.
[8] 张敏, 李娟. 窄谱中波紫外线联合保湿剂治疗慢性湿疹的临床观察[J]. 临床皮肤科杂志, 2024, 53(8): 478-481.
[9] 《中国中西医结合皮肤性病学杂志》2025年第24卷分类索引[J]. 中国中西医结合皮肤性病学杂志, 2025, 24(6): I0008-I0012.
[10] 曾玉娟. 麻杏薏甘汤治疗湿疹临床体会[J]. 实用中医药杂志, 2021, 37(5): 789-790.
[11] 东红阳, 彭孟凡, 王连睿, 等. 中药外用治疗慢性湿疹的现代机制及新进展[J]. 中华中医药杂志, 2025, 40(8): 4176-4180.
[12] 李彦梅, 马超超, 牛凡琪, 等. 基于JAK1/STAT5信号通路探讨肤痒静凝胶治疗慢性湿疹作用机制[J]. 中国临床药理学与治疗学, 2024, 29(9): 1011-1018.
[13] Incyte (2026) Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (Ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis. Incyte Corporation.
[14] 中华中医药学会皮肤科分会. 湿疹(湿疮)中医诊疗专家共识(2016版) [J]. 中国中西医结合皮肤性病学杂志, 2018, 17(2): 181-183.